Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R00DA041245-05S1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2018
    2021
  • Known Financial Commitments (USD)

    $160,369
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    Karsten Lunze
  • Research Location

    Russia
  • Lead Research Institution

    Boston Medical Center
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    Gender

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Drug users

  • Occupations of Interest

    Unspecified

Abstract

PROJECT Abstract: The COVID-19 pandemic restrictions to reduce the spread of the SARS-CoV-2 have exacerbated globalinequities. These restrictions may have particularly limited engagement in care of HIV-positive people whoinject drugs (PWID). This longitudinal project aims to qualitatively assess evolving consequences of theCOVID-19 pandemic on health risks and risk behaviors of HIV-positive PWID; and described the impact ofstigma on HIV-positive PWID during the COVID-19 pandemic. We will leverage access to the SCRIPT(R00DA041245) study population (n=108); SCRIPT is a community-based RCT testing the feasibility ofAcceptance and Commitment Therapy as a stigma intervention among PWID with HIV who are not connectedto addiction or HIV care in St. Petersburg, Russia. The SCRIPT study population provides a unique opportunityto understand pandemic impacts on substance use and HIV risk behaviors, as well as health care utilizationamong community-based HIV-positive PWID. This project will inform rights-based, gender-inclusivepreparedness strategies to mitigate adverse pandemic effects and prepare the key population of HIV-positivePWID for future pandemic situations.